Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
88°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALY
Recent news which mentions ESALY
< Previous
1
2
3
4
Next >
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
May 26, 2023
Tickers
ESALY
MRK
PFE
Tags
Market News
MRK
General
From
Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
May 04, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
BIIB
Analyst Ratings
Market News
From
Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
April 21, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Market News
BIIB
LLY
From
Benzinga
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
April 10, 2023
Tickers
ESALF
ESALY
MRK
Tags
Market News
General
MRK
From
Benzinga
Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories
April 03, 2023
Tickers
ATVI
BIIB
BOXD
CS
Tags
UBS
BOXD
BIIB
From
Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
April 03, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Alzheimer’s
News
ESALF
From
Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
March 31, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
BIIB
General
From
Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
March 21, 2023
Tickers
BIIB
ESALY
HRMY
INCY
Tags
NASDAQ:BIIB,NYSE:INSP,NASDAQ:INCY,NYSE:LLY,NYSE:MCK,NYSE:MRK,NASDAQ:HRMY,OTCMKTS:ESALY
MCK
Market News
From
InvestorPlace
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Government
Briefs
Benzinga
From
Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
March 14, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Large Cap
News
Health Care
From
Benzinga
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
March 06, 2023
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
General
FDA
From
Benzinga
Why Anavex Life Sciences Stock Bolted Higher in January
February 08, 2023
Tickers
AVXL
BIIB
ESALY
Tags
ESALY
AVXL
Recent Press Releases
From
Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
Tickers
APLS
BIIB
CYTK
EBS
Tags
LGND
REGN
Biotech
From
Benzinga
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
January 25, 2023
Tickers
BIIB
ESALY
LLY
Tags
LLY
ESALY
Recent Press Releases
From
Motley Fool
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
January 19, 2023
Tickers
BIIB
ESALY
Tags
Market News
Recent Press Releases
ESALY
From
Motley Fool
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
January 17, 2023
Tickers
ABBV
BIIB
ESALY
GOOG
Tags
ABBV
ESALY
GOOG
From
Motley Fool
Should You Buy Biogen Stock After Its Latest Alzheimer's Disease Drug Approval?
January 10, 2023
Tickers
BIIB
ESALY
Tags
ESALY
Recent Press Releases
Market News
From
Motley Fool
Barron's Top Weekend Stock Picks: Tesla, Snowflake, Delta And Why Warren Buffett's Berkshire Hathaway May Be In For Big Tax Bill
January 07, 2023
Tickers
BIIB
BRK-A
BRK-B
DAL
Tags
Media
DAL
Benzinga
From
Benzinga
FDA approves treatment for people with mild forms of Alzheimer’s
January 06, 2023
Tickers
BIIB
ESALY
SPX
Tags
SPX
ESALY
BIIB
From
MarketWatch
FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway
January 06, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
ESALY
Movers
From
Benzinga
Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?
January 06, 2023
Tickers
BIIB
ESALY
Tags
NASDAQ:BIIB,OTCMKTS:ESALY
Today's Market
BIIB
From
InvestorPlace
1 Stock Defying the Downturn to Buy, and 1 to Avoid
January 06, 2023
Tickers
AZN
BIIB
ESALY
Tags
ESALY
Recent Press Releases
Market News
From
Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Tickers
BGNE
BIIB
CDTX
CHRS
Tags
Trading Ideas
BIIB
MRK
From
Benzinga
1 Green Flag and 1 Red Flag for Biogen
December 23, 2022
Tickers
BIIB
ESALY
Tags
ESALY
Market News
Recent Press Releases
From
Motley Fool
Biogen's Alzheimer's Antibody Might Have A Third Death Associated With
December 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
General
BIIB
Market News
From
Benzinga
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
Tickers
CPRX
ESALF
ESALY
Tags
Briefs
ESALY
Benzinga
From
Benzinga
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
December 18, 2022
Tickers
BIIB
BNTX
ESALY
INCY
Tags
Market News
BNTX
BIIB
From
InvestorPlace
Better Bear Market Buy: Vertex Pharmaceuticals vs. Biogen Stock
December 18, 2022
Tickers
BIIB
CRSP
ESALY
VRTX
Tags
BIIB
VRTX
ESALY
From
Motley Fool
Eating these simple foods may slow Alzheimer’s by a third
December 16, 2022
Tickers
BIIB
ESALY
Tags
ESALY
BIIB
From
MarketWatch
Why 2023 Could Be a Big Year for Biogen
December 07, 2022
Tickers
BIIB
ESALY
Tags
BIIB
Recent Press Releases
Market News
From
Motley Fool
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.